title: Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease.
authors.forename: Gianluigi
authors.initials: G
authors.lastname: Ferretti
authors.forename: Alessandra
authors.initials: A
authors.lastname: Fabi
authors.forename: Alessandra
authors.initials: A
authors.lastname: Felici
authors.forename: Paola
authors.initials: P
authors.lastname: Papaldo
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab